89bio Shares Climb After Concluding Enrolment In Mid-Stage NASH Study
89bio (NASDAQ: ETNB) has completed enrollment in ENLIVEN, the Phase 2b trial of pegozafermin for the treatment of non-alcoholic steatohepatitis (NASH).
MindMed A Newly Minted Meme? College Student Who Made $100M On Bed Bath & Beyond Is Involved In Psychedelics Stock
A 20-year-old college student earned around $110 million after selling his stake in the troubled retailer Bed Bath & Beyond Inc (NASDAQ: BBBY) following the stock's recent rally of more than 339%, according to the Financi
U.S. Stocks Trade Lower; Weekly Jobless Claims Drop To 250,000
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 90 points on Thursday.
Expanding Distribution In Ontario Pays Off, Decibel Cannabis Hits Record Q2 Net Revenue
Decibel Cannabis Company Inc. (OTCQB: DBCCF) (TSX-V:DB) released its second quarter financial results for the three and six month periods ending June 30, 2022, revealing record net revenue of $18.6 million, with sequential growth of 11% over Q1 2022 and 49%
These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?
The Benzinga Cannabis Capital Conference in Chicago, September 13-14, will celebrate the most recognized Latin American cannabis companies.
Cantor Fitzgerald Cuts Price Target On This Cannabis MSO, But Touts Its Operations As ‘One Of Best-In-Class’
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) reported its financial results on Wednesday for the second quarter of fiscal 2022, revealing a 4% year-ove
Lowe’s To $252? Plus This Analyst Lowers Price Target On Otonomo Technologies By 67%
Goldman Sachs boosted the price target for Cisco Systems, Inc. (NASDAQ: CSCO) from $45 to $50. Cisco shares rose 5.1% to $49.02 in pre-market trading.
FDA Clears Curis’ Lymphoma Study, Keeping Leukemia Trial Still Stalled
The FDA has lifted the partial clinical hold on Curis Inc’s (NASDAQ:CRIS) TakeAim Lymphoma Phase 1/2 study of emavusertib after reviewing the…
Canaan Misses Q2 Revenue As Bitcoin Price Slump, COVID Lockdown Weigh On The Business
Canaan Inc (NASDAQ:CAN) reported second-quarter FY22 revenue growth of 52.8% year-on-year to $246.7 million, missing the consensus of $257.7 million. Earnings…